Back to Search

DAVID PRAGER, MD

MD

Otolaryngology Physician

NPI: 1508817636IndividualAccepts Medicare

Specialties, Licenses & Credentials

Otolaryngology PhysicianPrimary

Otolaryngology

Code: 207Y00000X

MD054167L(PA)25MA05769700(NJ)

CMS Specialties

PrimaryOTOLARYNGOLOGY

Education

OTHER

Class of 1986

Research & Publications (16)

Association of Cheyne-Stokes respiration and cardiac cachexia in congestive heart failure.
PMID 19097652·Int J Cardiol·2010
8-other
From Tucson to genomics and transgenics: the vector biology network and the emergence of modern vector biology.
PMID 19333394·PLoS Negl Trop Dis·2009
7-preclinical
CT, MRI, PET, PET/CT, and ultrasound in the evaluation of obstetric and gynecologic patients.
PMID 18381118·Surg Clin North Am·2008
6-review
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
PMID 17878479·J Clin Oncol·2007
3-trial
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
PMID 17050869·J Clin Oncol·2006
3-trial
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
PMID 15699477·J Clin Oncol·2005
3-trial
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
PMID 16043829·J Clin Oncol·2005
3-trial
Cell cycle effects of topotecan alone and in combination with irradiation.
PMID 15890420·Radiother Oncol·2005
8-other
Epizootiologic investigations of parvovirus infections in free-ranging carnivores from Germany.
PMID 15827228·J Wildl Dis·2005
7-preclinical
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
PMID 14570950·JAMA·2003
3-trial
Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
PMID 12410582·Am J Hematol·2002
5-case
Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma.
PMID 12001114·Cancer·2002
3-trial
Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy.
PMID 11490238·J Urol·2001
3-trial
Porcine teschoviruses comprise at least eleven distinct serotypes: molecular and evolutionary aspects.
PMID 11160660·J Virol·2001
7-preclinical
Detection of porcine enteroviruses by nRT-PCR: differentiation of CPE groups I-III with specific primer sets.
PMID 10960708·J Virol Methods·2000
7-preclinical
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.
PMID 10699069·J Natl Cancer Inst·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2851 BAGLYOS CIR, SUITE 201
BETHLEHEM, PA 18020

Location

Practice Location

2851 BAGLYOS CIR, BETHLEHEM, PA
(610) 867-7134

Quick Facts

NPI
1508817636
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
40
Publications
16

Are you this provider?

Claim Your Profile